GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
Status: Recruiting
Location: See all (6) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements.
• Patient has been or is intended to be treated with the TBE Device in Zone 0 or Zone 1.
• Patient is age ≥ 18 years at time of informed consent signature.
Locations
United States
Florida
University of Florida Health Heart & Vascular
RECRUITING
Gainesville
Lakeland Regional Medical Center
RECRUITING
Lakeland
North Carolina
Duke University Medical Center
RECRUITING
Durham
Texas
The Methodist Hospital-Houston
RECRUITING
Houston
Utah
Intermountain Medical Center
RECRUITING
Murray
Washington
University of Washington Medical Center
RECRUITING
Seattle
Contact Information
Primary
DeAnne Hart
tbe25-03@wlgore.com
800-437-8181
Time Frame
Start Date: 2026-03-02
Estimated Completion Date: 2036-03
Participants
Target number of participants: 125
Treatments
Other: GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device)
Related Therapeutic Areas
Sponsors
Leads: W.L.Gore & Associates